Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease

NCT03971617 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Insufficient enrollment to answer research question

Conditions

Parkinson Disease

Interventions

DRUG: Hydrogen
DRUG: Placebo oral tablet

Sponsor

Stony Brook University